Search results
Pfizer’s Earnings Are Due. Questions About the Company’s Outlook Linger.
Barrons.com· 4 hours agoFEATURE When Pfizer reports earnings on Wednesday, investors will be watching to see whether the...
Here's How to Play Pfizer (PFE) Stock Ahead of Q1 Earnings
Zacks via Yahoo Finance· 1 day agoPfizer (PFE) expects its operational revenues to improve, driven by its in-line products like...
Pfizer Sees Less Revenue From Covid-19 Treatments, Stock Faces Headwinds Ahead Of Q1 Earnings - ...
Benzinga· 9 hours agoPfizer's Q1 earnings report expects EPS of 49 cents and $13.09 billion in revenues. Stock has...
Pfizer and Genmab’s Tivdak wins full FDA approval for cervical cancer
Pharmaceutical Technology via Yahoo Finance· 11 hours agoPfizer and Genmab’s Tivdak (tisotumab vedotin-tftv) has won full approval from the US Food and Drug...
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology
Reuters via Yahoo Finance· 5 days ago(Reuters) -GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing...
Why I'm Buying This Beaten-Down, High-Yield Dividend Stock Hand Over Fist
Motley Fool via Yahoo Finance· 15 hours agoI owned shares of Pfizer (NYSE: PFE) when the COVID-19 pandemic started. Watching the stock soar...
FDA approves Labcorp companion diagnostic for Pfizer gene therapy
Medical Device Network via Yahoo Finance· 13 hours agoThe US Food and Drug Administration (FDA) has approved Labcorp’s nAbCyte Anti-AAVRh74var HB-FE assay...
5 Top Stocks to Buy in May
Motley Fool via Yahoo Finance· 13 hours agoThat's exactly how these Motley Fool contributors discuss Microsoft (NASDAQ: MSFT), Pfizer (NYSE: PFE), NextEra Energy (NYSE: NEE), Home Depot (NYSE:...
Pfizer to pay $25.5 mln to settle remaining Effexor XR antitrust claims
Reuters· 1 day agoPfizer has agreed to pay $25.5 million to resolve claims that its predecessor Wyeth conspired with...
Pfizer, Genmab Get Full FDA Approval for Cervical-Cancer Drug
Morningstar· 1 day agoPfizer and Genmab on Monday said they had received full approval from U.S. regulators for their treatment for certain forms of cervical cancer. The companies' drug Tivdak ...